Synthes Investor Blasts $21B J&J Deal In Suit
A Synthes Inc. stockholder sued the company in Delaware on Thursday over its proposed $21.3 billion acquisition by Johnson & Johnson, saying the price is too low and takes unfair advantage...To view the full article, register now.
Already a subscriber? Click here to view full article